Results 211 to 220 of about 54,012 (256)

Serum Pepsinogen as a Biomarker of Gastrointestinal Stromal Tumors (GIST) in Stomach. [PDF]

Cancer Med
Gao Z, Luo L, Han Y, Sun Y, Huang Y, Li S, Chen X, Yang H, Peng Z, Wang X, Zhao W, Wu X, Wu H, Bai J, Sun W, Zhou L, Ba Y.   +16 more
europepmc   +1 more source

Incidental Finding of Gastrointestinal Stromal Tumors in the Appendix. [PDF]

Cureus
Alshaikh S, Mubarak A, Alosaif N.
europepmc   +1 more source

Clinical characteristics and prognosis of elderly patients with gastric gastrointestinal stromal tumors: a population-based study. [PDF]

Transl Cancer Res
Xu Q, Xia M, Ni Y, Xu X, Qiao Z, Zhou L.
europepmc   +1 more source

Gastrointestinal Stromal Tumors

Current Oncology Reports
This review aims to outline the current understanding of the molecular drivers and treatment paradigms of gastrointestinal stromal tumors, with a focus on recent developments in treatment in the advanced disease setting.There have been recent advancements in our understanding of the molecular biology of gastrointestinal stromal tumors, including the ...
Gal, Strauss, Suzanne, George
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Gastrointestinal stromal tumors

Abdominal Imaging, 2006
We reviewed radiologic features of gastrointestinal stromal tumors (GISTs) and correlated them with clinical and pathologic findings.We investigated a series of 39 c-Kit-positive GISTs. Clinical and radiologic findings and management of these patients were recorded.Twenty women and 19 men (mean age 64 years) had histologically proved GIST.
A, Darnell, E, Dalmau, C, Pericay, E, Musulén, J, Martín, J, Puig, A, Malet, E, Saigí, M, Rey   +8 more
openaire   +4 more sources

Gastrointestinal stromal tumor

Surgical Oncology, 2008
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. These form a distinct category of tumors characterized by oncogenic mutations of the KIT receptor tyrosine kinase in a majority of patients. KIT is used not only for diagnosis but also for targeted therapy of GISTs.
Puneet, Gupta, Mallika, Tewari, Hari S, Shukla   +2 more
openaire   +2 more sources

Gastrointestinal Stromal Tumors

Hematology/Oncology Clinics of North America, 2005
Gastrointestinal stromal tumors (GISTs) are identified pathologically by the expression of KIT. The management of GISTs has been altered significantly by the development of imatinib mesylate, a tyrosine kinase inhibitor with activity against KIT and platelet-derived growth factor receptors.
Margaret, von Mehren, James C, Watson
openaire   +2 more sources

Gastrointestinal Stromal Tumors

American Journal of Therapeutics, 2016
The understanding of aberrant molecular pathways that result in gastrointestinal stromal tumors (GISTs) and the rapid development of molecular therapies that target these pathways represent one of the great milestones in translational oncology.
Aakanksha Prasad, Asija, Alex V, Mejia, Anthony, Prestipino, Madhavan V, Pillai   +3 more
openaire   +2 more sources

Gastrointestinal stromal tumors and leiomyosarcomas

Journal of Surgical Oncology, 2008
AbstractOnly recently has gastrointestinal stromal tumor (GIST) been recognized as the most frequent GI mesenchymal neoplasm. Prior to the use of KIT staining, most GI stromal tumors were identified as leiomyosarcoma (LMS). For primary GIST, surgery remains the principal treatment and adjuvant imatinib may improve outcomes.
Steven C, Katz, Ronald P, DeMatteo
openaire   +2 more sources

Gastrointestinal stromal tumor of the anus

Techniques in Coloproctology, 2003
We report a rare case of gastrointestinal tumor of the anus with an unusual presentation as a perianal lipoma. A 65-year-old man presented with a 2-month history of a painless perianal lump clinically resembling a perianal lipoma. Endoanal ultrasonography revealed a 3 x 3 cm2 mass in the intersphincteric plane. Following initial excision of the lesion,
G Y M, Tan, C K, Chong, K W, Eu, P H, Tan   +3 more
openaire   +2 more sources